GERI SCRIPT L L C NPI 1922044387

NPI Details

GERI SCRIPT L L C is a long term care pharmacy pharmacy in Pompton Plains, NJ. The provider is a pharmacy that dispenses medicinal preparations delivered to patients residing within an intermediate or skilled nursing facility, including intermediate care facilities, hospice, assisted living facilities, group homes, and other forms of congregate living arrangements. GERI SCRIPT L L C NPI is 1922044387. The provider is registered as an organization entity type.
The provider Is Doing Business As Geriscript Pharmacy, Llc.

The provider's business location address is:

220 W PARKWAY
POMPTON PLAINS, NJ
ZIP 07444-013
Phone: (973) 890-7735
Fax: (973) 835-8700

The provider's authorized official is Morris Meisels .
The authorized official title is Executive Vice President and has the following contact phone number (973) 890-7735.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Fee covid-19 vac 13 res (HCPCS:0124A)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose (HCPCS:0002A)
• Adm sarscv2 30mcg trs-sucr 2 (HCPCS:0052A)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, single dose (HCPCS:0031A)
• Adm sarscov2 vac ad26 .5ml b (HCPCS:0034A)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)

The enumeration date for this NPI number is 6/22/2006 and was last updated on 6/20/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.